Schizophrenia Clinical Trial
Official title:
A Randomized Controlled Trial of Brief Culturally Adapted CBT for Schizophrenia in Pakistan
While Cognitive behavior therapy for psychosis (CBTp) is now established as an effective and evidence based therapy for psychotic illnesses in the west and is recommended by the national organizations both in Europe and in the USA. However, CBT remains limited to the western clients. We have adapted CBT for psychosis in Pakistan for use with local clients. Initial evaluations have found that these therapies are effective. Due to the financial restraints we would like to test a brief version of the Culturally adapted CBTp (CaCBTp) in Pakistan. We want to see if brief CaCBTp (6 sessions of CBT) would be effective in non western cultures in educing symptoms of schizophrenia. This study will test brief CaCBTp against care as usual in Pakistan in secondary care.
BACKGROUND A number of systematic reviews and meta-analyses (for example, Wykes, Steel,
Everitt, & Tarrier, 2008) have concluded that Cognitive Behaviour Therapy (CBT) is effective
in treating people with schizophrenia. Most of this work was however, conducted in the West.
In a literature search no study of CBT for psychosis in English language literature was
found from a low or middle income country, including from Pakistan. Only two studies of
psychological interventions for schizophrenia were found from Pakistan (Farooq et al., 2011;
Nasr, Kausar, & others, 2009).
It has been suggested that cultural differences can influence the process of Cognitive
Behaviour Psychotherapy, and therefore therapy might need adapting to the cultural needs of
a given country. Our group has adapted Cognitive Therapy for depression in Pakistan (F.
Naeem, Ayub, Gobbi, & Kingdon, 2009; F. Naeem, Gobbi, Ayub, Kingdon, & others, 2010; Farooq
Naeem, Ayub, Kingdon, & Gobbi, 2012; Farooq Naeem, Gobbi, Ayub, & Kingdon, 2009) , which was
found to be effective in a small trial (Farooq Naeem, Waheed, Gobbi, Ayub, & Kingdon, 2011).
Same methodology was useed to adapt CBT for schizophrenia for local use (Naeem et al, under
review). A small pilot found it to be effective in inpatient settings. (Habib et al, under
review). This is a RCT to test the effectiveness of Culturally adapted CBT for psychosis
(CaCBTp).
METHODS Aims The aim of this RCT is to test brief culturally adapted Cognitive Therapy for
Schizophrenia against Treatment As Usual in Pakistan.
Study area and population:
Study participants will be recruited mainly from hospitals in Lahore/Karachi, Pakistan.
Sample Inclusion criteria include;
- living within travelling distance of the hospital
- and with a diagnosis of Schizophrenia according to ICD10, RDC
- age between 18 to 65 years
- and at least 5 years of education/ or the main carer with at least 5 years of
education. The exclusion criteria include;
- co-morbid alcohol or substance dependence
- organic brain syndrome or learning disability
- and high levels of disturbed behavior/or high risk of suicide or homicide.
Sample size The sample size was calculated on showing a difference in the post-treatment
PANSS positive symptoms score between groups. A previous study (reference in here?) found a
standard deviation for the post-treatment scores of 5.8 in the control group, and 1.8 in the
CBT group. In the analysis, the pre-treatment scores will be adjusted for, and the previous
study found a correlation of 0.2 between the pre and post treatment scores. A difference
between groups of 15% of the pre-treatment values would be regarded as being of clinical
importance. This equates to a difference of 3 units on the PANNS positive symptoms score
scale. Using a 5% significance level and 90% power, it is calculated that 41 subjects per
group are required, 82 in total. It is expected that up to 30% of patients may drop-out of
the study. To allow for this, a total of 120 patients will be recruited into the study.
Procedure Mental health professional from the hospitals will be contacted and the purpose of
the study will be explained to them. Patients referred by them received information about
the study. After taking informed consent participants will be assessed by blind assessors
who will be psychology graduates and had received one day training in using assessment
tools. After completion of the assessment, participants will be randomly assigned to either
CBT or Treatment As Usual group. Randomization will be performed using randomization.com.
Ethical approval The Ethics Committee of Pakistan Association of Cognitive Therapists (PACT)
has granted ethical approval for this study.
Measures Data regarding demographic characteristics will be collected using a data
collection form. Psychopathology will be measured using the PANSS (Positive and Negative
Syndrome Scale of Schizophrenia), PSYRATS (Psychotic Symptom Rating Scales), and the Insight
Scale. The above scales were translated into Urdu using standard methodology(Ahmer, Faruqui,
& Aijaz, 2007). Positive and Negative Syndrome Scale of Schizophrenia (PANSS) (Kay,
Flszbein, & Opfer, 1987) is a widely used, well established and comprehensive symptom rating
scale measuring mental state. It has 30 items, each measured on a seven point rating
instrument. There are three sub-scales (Positive Symptoms, Negative Symptoms and General
Psychopathology) along with a total score. The test re test reliability of PANSS is 0.88 and
Criterion related validity is 0.62. The Structured Clinical Interview for PANSS (SCI-PANSS)
(Kay, 1991) was used in this study.
Psychotic Symptom Rating Scales (PSYRATS) (Gillian Haddock, McCarron, Tarrier, & Faragher,
1999) is a 17 item interviewer scored instrument which consist of 2 subscales (PSYRATS
Voice, PSYRAT Delusion) which measures the severity of a number of dimensions of auditory
hallucinations and delusions including the amount and intensity of distress associated with
these symptoms. The 11 item hallucination sub-scale consists of items such as frequency,
duration, loudness, negative content, intensity of distress and degree of disruption. The
six item delusion sub-scale (PSYRATS delusion) consists of items such as amount of
pre-occupation, degree of conviction, intensity of distress and disruption. All items are
rated on a five point scale of increasing severity (0 = No problem to 4 = Maximum severity).
The PSYRATS has demonstrated good inter rater reliability (intra class correlation (ICCS)
for most item > .90), test re test reliability (ICCS for both subscales = .70), concurrent
validity, and sensitivity to change in patients diagnosed with Schizophrenia.
Insight will be rated using the Schedule for Assessment of Insight (SAI) (David, Buchanan,
Reed, & Almeida, 1992). The SAI rates three dimensions of insight; Treatment Adherence
(SAI-TA), Recognition of Illness (SAI-RI) and Symptom Relabelling (SAI-SR). Symptom
Relabelling involves the recognition of a psychotic symptom and the understanding that it is
a pathological event. Each dimension comprises two or three questions which are scored on a
3-point scale from 0 (no insight) to 2 (good insight), with a maximum total score of 24. The
sub-scale totals are summed for a total insight score.
Brief disability rating questionnaire will be used to measure change in level of disability.
Intervention The CBT intervention will consist of 6 session sessions lasting approximately
one hour. There will be one additional session for the family. It has been observed that
family members are involved actively in patient care in Pakistan, so the main carer/family
member will be involved in the treatment plan from the beginning. A key carer will be
identified with whom researcher will work in close collaboration. This person helped with
homework if required. The sessions will be planned according to a manualized treatment
protocol (Kingdon & Turkington, 1994). Therapy will be delivered using guidelines developed
for cultural adaptation in Pakistan and therapists will receive regular supervision on
skype. CBT was adapted using a series of qualitative studies (Naeem et al, 2010, 2009, 2010,
2009, accepted for publication, under review). An initial pilot project found this
culturally adapted CBT for psychosis to be effective in Pakistan (Habib et al, unde review)
TAU Group The Treatment As Uusual (TAU) group will receive only antipsychotic medication as
prescribed by the psychiatrist, regular follow up and nursing care.
STATISTICAL ANALYSES Both parametric and non parametric tests will be carried out. Initially
data will be examined for errors in input. The analysis will be carried out on intention to
treat basis using SPSS version 16.0. Initial analyses to compare the two groups were carried
out using t test and χ2 test. A linear regression analysis will be used, with end of therapy
as the dependent variable and group allocation, as independent variable. In order to see the
effect of baseline differences in pre treatment scores on effect of therapy a second
analysis was carried out with baseline scores entered as independent variables in addition
to treatment groups (i.e., dependent variable post treatment scores, independent variable
treatment group and pre treatment scores).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |